Adler, G., Müller, B., & Articus, K. (2014). The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer’s disease under daily practice conditions. The international journal of clinical practice, 68(4), . https://doi.org/10.1111/ijcp.12374
Chicago-Zitierstil (17. Ausg.)Adler, Georg, Beate Müller, und Konstantin Articus. "The Transdermal Formulation of Rivastigmine Improves Caregiver Burden and Treatment Adherence of Patients with Alzheimer’s Disease Under Daily Practice Conditions." The International Journal of Clinical Practice 68, no. 4 (2014). https://doi.org/10.1111/ijcp.12374.
MLA-Zitierstil (9. Ausg.)Adler, Georg, et al. "The Transdermal Formulation of Rivastigmine Improves Caregiver Burden and Treatment Adherence of Patients with Alzheimer’s Disease Under Daily Practice Conditions." The International Journal of Clinical Practice, vol. 68, no. 4, 2014, https://doi.org/10.1111/ijcp.12374.